Studies have observed that treatments increasing CD4+ T cell infiltration in TNBC can amplify the anti-tumor immune response, particularly when CD4+ cells foster CD8+ T cell proliferation, differentiation, and retention within the tumor microenvironment [48]. Here, CD8A is linked to neoplasm.